The power of Hope, Dreambox – a project about breast cancer
is an Norwegian interactive art project, where the mainstay of women’s experiences with breast cancer is central. Roche Norway and the... Learn More
Immunotherapy: the revolution cancer care needs
Dr. Eric Walk explains the future of cancer immunotherapy and how it’s changing treatment right now Subscribe to our YouTube channel now:... Learn More
Sport und Bewegung mit Lungenkrebs. Auf das richtige Mass kommt es an!
Im Video berichten Menschen mit Lungenkrebs, welche Bedeutung Bewegung und Sport in ihrem Leben haben – und wie sie als Betroffene das... Learn More
Lungenkrebspatienten verstehen und beistehen
Betroffene und deren Angehörige erzählen, wie sie mit der Lungenkrebs Diagnose umgegangen sind und wie sie sich gegenseitig unterstützt haben. Ehe, Partnerschaft,... Learn More
Wie geht man mit dem Thema Sterben um?
Wie geht man mit dem Thema Sterben um? Lungenkrebspatienten erzählen, wie sie sich mit dem Thema Sterben auseinandersetzen und wie sich ihre... Learn More
Focus on follicular lymphoma: the patient’s journey
Blood cancer is the fifth-highest cause of cancer death worldwide, and lymphoma is one of its most prevalent forms. Follicular lymphoma is... Learn More
Risk factors for developing triple-negative breast cancer
Breast cancer is the most common cancer in women. Among the 1.67 million women diagnosed each year, 15% are diagnosed with triple-negative... Learn More
Unleashing the T-cell army: cancer immunotherapy at Roche
Cancer immunotherapy helps us enhance our immune systems so that they’re able to fight cancer, enabling our bodies’ T-cell armies to attack... Learn More
Breast cancer: One diagnosis, hundreds of lives impacted
Every 20 seconds someone is told they have breast cancer. Behind every diagnosis is a personal story, which impacts the lives of... Learn More
The early breast cancer treatment approach: “neoadjuvant” and “adjuvant”
Treating breast cancer early – before it has spread – may improve the chances of preventing the disease from returning and reaching... Learn More
Early-stage breast cancer diagnosis: Ike’s story of hope
Ike was diagnosed with HER2-positive breast cancer at the age of 38. Fortunately, she was diagnosed at an early stage, before the... Learn More
Drawn to Science: Innovative clinical trial design
As our understanding of disease advances, traditional clinical trial designs are becoming less and less viable. Two innovations in this area –... Learn More
Drawn to Science: clinical trials
Our Drawn to Science series shows you some of the cool things Roche scientists do in their labs and clinics to discover... Learn More
Express your cells – the sound of cancer
A scientist, a pop star and a patient joined together to create a musical composition based on a the patient’s biopsy in... Learn More
Understanding more about why quality of life matters
The film provides explanations on what quality of life really means, how a physician can make a difference to a patient’s quality... Learn More
Vivian, breast cancer survivor
Vivian, a mother of three children, had metastatic breast cancer and was successfully treated. “When they told me I had breast cancer... Learn More
What is pathological complete response (pCR) and why is it important?
To determine whether a cancer medicine works in clinical trials, scientists typically use measurements called endpoints. In patients with early breast cancer,... Learn More
How tumours progress over time: breast cancer
It is easy to miss something that’s difficult to see, so breast cancer tumour growth may go unnoticed. That’s why it’s important... Learn More
The difference a scarf can make for people living with breast cancer
In Hadassah oncology institute Jerusalem, Israel, breast cancer patients gained their privacy and comfort with big pink scarfs given to them in... Learn More
Roche CEO Severin Schwan on cancer immunotherapy
Roche CEO Severin Schwan talks about cancer immunotherapy, which aims to help a person’s own immune system recognise and attack cancer. For... Learn More
Drawn to Science: T-cell bispecific antibodies
Engineered antibodies can be designed to help the body’s own defence mechanisms fight diseases. At Roche Pharma Research and Early Development, we... Learn More
Cancer immunotherapy: the PD-L1 pathway
The role of the immune system is to protect the body from foreign invaders. In responding to cancer, T cells play a... Learn More
Understanding bladder cancer: the facts
Bladder cancer is one of the world’s top ten most common cancers. Approximately 165,000 deaths are attributed to the disease globally each... Learn More